- Home
- VSA vs PHIO Comparison
VSA vs PHIO Comparison
Compare VSA & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- PHIO
- Stock Information
- Founded
- VSA 2002
- PHIO 2011
- Country
- VSA China
- PHIO United States
- Employees
- VSA N/A
- PHIO N/A
- Industry
- VSA
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- PHIO Health Care
- Exchange
- VSA NYSE
- PHIO Nasdaq
- Market Cap
- VSA 7.9M
- PHIO 8.6M
- IPO Year
- VSA N/A
- PHIO N/A
- Fundamental
- Price
- VSA N/A
- PHIO $2.40
- Analyst Decision
- VSA
- PHIO Strong Buy
- Analyst Count
- VSA 0
- PHIO 2
- Target Price
- VSA N/A
- PHIO $9.00
- AVG Volume (30 Days)
- VSA 251.6K
- PHIO 706.1K
- Earning Date
- VSA 08-21-2025
- PHIO 08-13-2025
- Dividend Yield
- VSA N/A
- PHIO N/A
- EPS Growth
- VSA N/A
- PHIO N/A
- EPS
- VSA N/A
- PHIO N/A
- Revenue
- VSA $160,411,283.00
- PHIO N/A
- Revenue This Year
- VSA N/A
- PHIO N/A
- Revenue Next Year
- VSA N/A
- PHIO N/A
- P/E Ratio
- VSA N/A
- PHIO N/A
- Revenue Growth
- VSA N/A
- PHIO N/A
- 52 Week Low
- VSA $0.18
- PHIO $0.97
- 52 Week High
- VSA $2.00
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- PHIO 55.88
- Support Level
- VSA N/A
- PHIO $2.11
- Resistance Level
- VSA N/A
- PHIO $2.53
- Average True Range (ATR)
- VSA 0.00
- PHIO 0.15
- MACD
- VSA 0.00
- PHIO -0.00
- Stochastic Oscillator
- VSA 0.00
- PHIO 74.62
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has two operating segments: the IT Professional Education segment and the IT-focused Supplementary STEM Education Services segment. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.